Health care resource utilization (HCRU) and costs in patients with biliary tract cancer (BTC) treated with systemic therapy in the United States (US).

Authors

null

Liya Wang

Merck & Co., Inc., Kenilworth, NJ

Liya Wang , Mukul Singhal , Madhulika Eluri , Adriana Valderrama , Bal Nepal , Shital Kamble , Michael Grabner , Usha Malhotra , Abby B. Siegel , Shilpi Swami , Milind M. Javle

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 4090)

DOI

10.1200/JCO.2022.40.16_suppl.4090

Abstract #

4090

Poster Bd #

77

Abstract Disclosures

Similar Posters

First Author: Hartmut Goldschmidt

First Author: Brad Schenkel

First Author: Tycel Jovelle Phillips

First Author: Preeti Kakani